Testicular dysfunction
Methodology & AI Transparency ⓘ
Testicular dysfunction Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as E29.9, Testicular dysfunction falls under Men's Health & TRT management, where blood pressure) [Testicular dysfunction E29.9] establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Diagnostic registry E29.9: Testicular dysfunction is managed within Men's Health & TRT.
- 3 Typical cash cost range: Workup highlights for Testicular dysfunction (E29.9): blood pressure) [Testicular dysfunction E29.9].
- 4 Top reported side effects / signs: Longitudinal Testicular dysfunction monitoring tracks LH, FSH & in Testicular dysfunction (E29.9: SHBG) toward LH/FSH 2.5 – 8.0 mIU/mL (E29.9).
Ask our AI Specialists anything about Testicular dysfunction
What Is Testicular dysfunction?
Designated in federal medical registries as E29.9, Testicular dysfunction falls under Men's Health & TRT management, where blood pressure) [Testicular dysfunction E29.9] establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Testicular dysfunction (E29.9) center on impaired cavernosal endothelial in Testicular dysfunction (E29.9: nitric oxide-cGMP smooth-muscle). targeted men's health & trt interventions aim to normalize LH, FSH & in Testicular dysfunction (E29.9: SHBG).
Common Symptoms & Clinical Signs
- • Presentation of Testicular dysfunction (E29.9): reduced sexual desire, in Testicular dysfunction (E29.9: fewer spontaneous morning)
- • Secondary Testicular dysfunction clinical sign: loss of lean in Testicular dysfunction (E29.9: muscle recovery, rising)
- • Symptom flares in Testicular dysfunction correlating with LH, FSH & in Testicular dysfunction (E29.9: SHBG) deviation outside LH/FSH 2.5 – 8.0 mIU/mL (E29.9)
- • Functional men's health & trt impact requiring blood pressure) [Testicular dysfunction E29.9] evaluation (E29.9)
Testicular dysfunction Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E29.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Men's Health, Testosterone & Sexual Function | NLM Clinical Tables |
| Diagnostic / Lab Marker: LH, FSH & in Testicular dysfunction (E29.9: SHBG) | LH/FSH 2.5 – 8.0 mIU/mL (E29.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hematocrit & Total in Testicular dysfunction (E29.9: PSA) | Hct < 50%; age-appropriate PSA (E29.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ultrasensitive Estradiol & in Testicular dysfunction (E29.9: ApoB) | E2 20–38 pg/mL; ApoB < 80 mg/dL (E29.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Testicular dysfunction
Treatment selection for Testicular dysfunction depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Testicular dysfunction)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of Combination Comprising Tamsulosin and PDE5-Is, Relative to: What a 1,144-Participant Study Found However, therapy discontinuation due to pain and AEs did not increase with increase in AEs. American journal of men's health • 2020-01-15 • Meta-Analysis | N = 1,144 | 94/100 | PMID 33342335 ↗ |
| New Insights on Glucagon-like peptide 1 receptor agonists on testicular: What a 680-Participant Study Found Our systematic review and meta-analysis suggest a possible role for GLP-1RAs in the therapy of functional hypogonadism related to overweight and obesity, while also promoting weight loss. Andrology • 2025-11-15 • Meta-Analysis | N = 680 | 91/100 | PMID 40105090 ↗ |
| Can This Approach Help? Inside the Latest Research on A randomized, gold-standard blind, compared against a dummy pill (placebo) trial • Long-acting testosterone is effective in improving health-related quality of life as assessed by the AMS scale in men with TDS. BJU international • 2012-07-15 • Randomized Controlled Trial | N = 120 | 88/100 | PMID 22093057 ↗ |
| Can This Approach Help? Inside the Latest Research on Gold-standard blind group comparative study of testosterone undecanoate and TU induced a marked improvement of the sexual activity and of the mental state. Journal of endocrinological investigation • 1980-01-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 7000879 ↗ |
| Can This Approach Help? Inside the Latest Research on Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men Testosterone replacement of older hypogonadal men with unexplained anemia stimulates erythropoiesis associated with increased iron mobilization. The Journal of clinical endocrinology and metabolism • 2020-11-01 • Randomized Controlled Trial | N = 58 | 88/100 | PMID 32785689 ↗ |
Testicular dysfunction Patient Community & “People Like Me” Threads
Filter Testicular dysfunction community threads and patient logs by age, biological sex, dosage, and treatment duration.